English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
Honda Plans to Establish Comprehensive Electric Vehicle Value Chain in Ontario, Canada
Apr 29, 2024 13:16 HKT
TAXCOM Middle East Summit 2024: Empowering Tax Professionals to Navigate a Complex Landscape
Apr 29, 2024 12:28 HKT
StrategINK Unveils 3rd Edition of VISION'24: Pacing Today, Pioneering Tomorrow
Apr 29, 2024 12:09 HKT
Wintermar Offshore (WINS:JK) Reports 1Q2024 Results
Apr 29, 2024 12:00 HKT
Total Active Hub Partners with Cleo to Enhance Rewards Engine with Blockchain Technology
Apr 29, 2024 08:25 HKT
HKTDC unveils gifts, printing, packaging and licensing events
Apr 27, 2024 20:00 HKT
Masverse Unveils Groundbreaking Blockchain Platform
Apr 27, 2024 02:40 HKT
Spritzer Scores Big with 'Meet the Red Legends' Event for Football Fans
Apr 26, 2024 23:00 HKT
Announcing Mad About Marketing - A New Member of the Digital Sukoon Private Limited Family
Apr 26, 2024 22:25 HKT
FinTech Funding Continues to Surge as Second Edition of Dubai FinTech Summit Commences
Apr 26, 2024 21:10 HKT
汇聚科技有限公司公布截至二零二三年十二月三十一日止末期业绩

Apr 26, 2024 18:53 HKT
匯聚科技有限公司公佈截至二零二三年十二月三十一日止末期業績
Apr 26, 2024 18:43 HKT
UK advertising reports GBP36.6bn spend in 2023
Apr 26, 2024 18:30 HKT
TIME Interconnect Technology Limited Announces Final Results For The Nine Months Ended 31 December 2023
Apr 26, 2024 18:26 HKT
UK advertising reports GBP36.6bn spend in 2023
Apr 26, 2024 17:30 HKT
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine
Apr 26, 2024 16:36 HKT
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine
Apr 26, 2024 15:36 HKT
可持续发展三大支柱引领 海通恒信ESG必答卷高分亮相
Apr 26, 2024 15:28 HKT
可持續發展三大支柱引領 海通恆信ESG必答卷高分亮相
Apr 26, 2024 15:25 HKT
Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project
Apr 26, 2024 14:34 HKT
<< Previous Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: